Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01035567

Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease (POL-MIDES)

Prospective Randomised Pilot Study Evaluating the Safety and Efficacy of Hybrid Revascularization in Multivessel Coronary Artery Disease

Sponsor: Ministry of Science and Higher Education, Poland

Conditions Coronary Artery Disease Coronary Disease Heart Disease Myocardial Ischaemia

Interventions Coronary Artery Bypass Grafting Hybrid revascularization

Updated 5 times since 2017 Last updated: Dec 1, 2013 Started: Nov 30, 2009 Primary completion: May 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Coronary Artery Disease and Coronary Disease and is currently completed. Ministry of Science and Higher Education, Poland leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Science and Higher Education, Poland
Silesian Centre for Heart Diseases

Data source: Silesian Centre for Heart Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zabrze, Poland